Molecular Devices Announces Webcast of Presentation at UBS Global Life Sciences Conference

Molecular Devices Announces Webcast of Presentation at UBS Global
Life Sciences Conference 


SUNNYVALE, Calif., Sept. 21  /PRNewswire-FirstCall/ -- Molecular Devices
Corporation (NASDAQ:MDCC), a leader in innovative solutions for drug discovery
and life sciences research, today announced that Joseph D. Keegan, Ph.D., CEO
and President, will present at the UBS Global Life Sciences Conference,
Wednesday, September 29, 2004 at 12:00 noon (Eastern), at the Grand Hyatt New
York.

Molecular Devices' audio presentation will be webcast live, and can be accessed
at:  http://www.ibb.ubs.com/ or on the investor page at the Company's website
http://www.moleculardevices.com/.

The audio presentation will be archived on the Company's website for 5 days.

Molecular Devices Corporation is a leading developer of high-performance,
bioanalytical measurement systems that accelerate and improve drug discovery
and other life sciences research.  Molecular Devices' systems and consumables
enable pharmaceutical and biotechnology companies to leverage advances in
genomics and combinatorial chemistry by facilitating the high-throughput and
cost-effective identification and evaluation of drug technologies that
integrate its expertise in engineering, molecular and cell biology, and
chemistry.  Molecular Devices enables its customers to improve research
productivity and effectiveness, which ultimately accelerates the complex
process of discovering and developing new drugs. 

DATASOURCE: Molecular Devices Corporation



CONTACT:  Tim Harkness of Molecular Devices Corporation, [phone]



Web site:  http://www.moleculardevices.com/ 

Copyright